|
12 Companies |
|
10 Products |
|
10 Products |
|
19 Mechanisms of Action |
|
0 Trials |
|
90 News |
|
| 12» |
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: LUVIA: The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism (clinicaltrials.gov) - Dec 28, 2018
P=N/A, N=10, Completed, Sponsor: Johns Hopkins University
Recruiting --> Completed | N=28 --> 10 | Trial completion date: Dec 2018 --> Apr 2018 | Trial primary completion date: Dec 2018 --> Apr 2018
- | atorvastatin / Generic mfg.
Trial completion, Trial completion date: Atorvastatin in Active Vitiligo (clinicaltrials.gov) - Feb 5, 2018
P2, N=28, Completed, Sponsor: Centre Hospitalier Universitaire de Nice
Recruiting --> Completed | N=28 --> 10 | Trial completion date: Dec 2018 --> Apr 2018 | Trial primary completion date: Dec 2018 --> Apr 2018 Active, not recruiting --> Completed | Trial completion date: Oct 2017 --> Dec 2017
- | Phase classification: Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo (clinicaltrials.gov) - Dec 19, 2017
P=N/A, N=2, Terminated, Sponsor: Johns Hopkins University
Active, not recruiting --> Completed | Trial completion date: Oct 2017 --> Dec 2017 Phase classification: P4 --> P=N/A
- | Trial primary completion date: LUVIA: The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism (clinicaltrials.gov) - Dec 14, 2017
P=N/A, N=28, Recruiting, Sponsor: Johns Hopkins University
Phase classification: P4 --> P=N/A Trial primary completion date: Sep 2017 --> Dec 2018
- | pirfenidone / Generic mfg.
Trial completion: Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome (clinicaltrials.gov) - Oct 15, 2017
P2, N=35, Completed, Sponsor: William Gahl, M.D.
Trial primary completion date: Sep 2017 --> Dec 2018 Active, not recruiting --> Completed
- | Enrollment change, Trial termination: Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo (clinicaltrials.gov) - Jul 25, 2017
P2/3, N=22, Terminated, Sponsor: Rutgers, The State University of New Jersey
N=60 --> 22 | Recruiting --> Terminated; Principal investigator made the decision to close study and not submit a renewal. Lack of fixed research personnel to carry out the study effectively.
- | Trial completion, Enrollment change: Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo (clinicaltrials.gov) - Apr 10, 2017
P=N/A, N=3258, Completed, Sponsor: St. Luke's-Roosevelt Hospital Center
Lack of fixed research personnel to carry out the study effectively. Recruiting --> Completed | N=1500 --> 3258
- Trial completion: Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients (clinicaltrials.gov) - Apr 4, 2017
P4, N=10, Completed, Sponsor: Netherlands Institute for Pigment Disorders
Recruiting --> Completed | N=1500 --> 3258 Enrolling by invitation --> Completed
- | atorvastatin / Generic mfg.
Enrollment closed, Trial primary completion date: Atorvastatin in Active Vitiligo (clinicaltrials.gov) - Mar 31, 2017
P2, N=28, Active, not recruiting, Sponsor: Centre Hospitalier Universitaire de Nice
Enrolling by invitation --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: May 2016 --> Feb 2017
- tacrolimus topical / Generic mfg.
New trial, Head-to-Head: Comparison of Cyclic On-off and Continuous Excimer Laser Treatment for Vitiligo (clinicaltrials.gov) - Feb 9, 2017
P=N/A, N=12, Completed, Sponsor: Ajou University School of Medicine
- Orfadin (nitisinone) / Astellas, SOBI
Trial primary completion date: Nitisinone for Type 1B Oculocutaneous Albinism (clinicaltrials.gov) - Jan 31, 2017
P1/2, N=5, Active, not recruiting, Sponsor: National Eye Institute (NEI)
Recruiting --> Active, not recruiting | Trial primary completion date: May 2016 --> Feb 2017 Trial primary completion date: Dec 2017 --> Jul 2016
- Trial completion, Trial primary completion date: Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment (clinicaltrials.gov) - Jan 12, 2017
P=N/A, N=11, Completed, Sponsor: Medical University of Graz
Trial primary completion date: Dec 2017 --> Jul 2016 Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Dec 2015
- Trial primary completion date: Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo (clinicaltrials.gov) - Jan 10, 2017
P2/3, N=60, Recruiting, Sponsor: Rutgers, The State University of New Jersey
Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Sep 2015 --> Jan 2018
- Enrollment change, Trial termination: Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo (clinicaltrials.gov) - Oct 18, 2016
P4, N=2, Terminated, Sponsor: Johns Hopkins University
Trial primary completion date: Sep 2015 --> Jan 2018 N=30 --> 2 | Recruiting --> Terminated; Lack of enrollment and staff availability to administer treatment.
- Orfadin (nitisinone) / Astellas, SOBI
Enrollment closed, Enrollment change, Trial primary completion date: Nitisinone for Type 1B Oculocutaneous Albinism (clinicaltrials.gov) - Sep 15, 2016
P1/2, N=5, Active, not recruiting, Sponsor: National Eye Institute (NEI)
N=30 --> 2 | Recruiting --> Terminated; Lack of enrollment and staff availability to administer treatment. Recruiting --> Active, not recruiting | N=50 --> 5 | Trial primary completion date: Dec 2016 --> Dec 2017
- | Enrollment change, Trial primary completion date: Autologous Transplantation of Melanocytes for Treatment of Vitiligo Skin (clinicaltrials.gov) - Jul 20, 2016
P3, N=300, Completed, Sponsor: Royan Institute
Recruiting --> Active, not recruiting | N=50 --> 5 | Trial primary completion date: Dec 2016 --> Dec 2017 N=100 --> 300 | Trial primary completion date: Apr 2011 --> Feb 2015
- Trial completion, Enrollment change: Excimer Light Treatment for Idiopathic Guttate Hypomelanosis: A Pilot Study (clinicaltrials.gov) - Apr 19, 2016
P=N/A, N=6, Completed, Sponsor: Seton Healthcare Family
N=100 --> 300 | Trial primary completion date: Apr 2011 --> Feb 2015 Active, not recruiting --> Completed | N=20 --> 6
- fluticasone propionate / Generic mfg.
Enrollment change, Trial withdrawal, Combination therapy: Fractional Laser in Combination With UVB Therapy in Vitiligo Patients (clinicaltrials.gov) - Apr 18, 2016
P=N/A, N=0, Withdrawn, Sponsor: Netherlands Institute for Pigment Disorders
Active, not recruiting --> Completed | N=20 --> 6 N=20 --> 0 | Recruiting --> Withdrawn
- ACH24 / Ache Lab
Enrollment change, Trial withdrawal: Efficacy and Safety of ACH24 in the Treatment of Vitiligo (clinicaltrials.gov) - Mar 16, 2016
P3, N=0, Withdrawn, Sponsor: Ache Laboratorios Farmaceuticos S.A.
N=20 --> 0 | Recruiting --> Withdrawn N=94 --> 0 | Not yet recruiting --> Withdrawn
- | Trial completion, Enrollment change, Trial primary completion date: Photocil (Topical) for the Treatment of Vitiligo (clinicaltrials.gov) - Mar 10, 2016
P=N/A, N=15, Completed, Sponsor: Applied Biology, Inc.
N=94 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Completed | N=50 --> 15 | Trial primary completion date: Jul 2014 --> Dec 2014
- Enrollment change, Trial termination, Trial primary completion date: Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo (clinicaltrials.gov) - Jan 27, 2016
P2, N=4, Terminated, Sponsor: Centro Studi Gised
Recruiting --> Completed | N=50 --> 15 | Trial primary completion date: Jul 2014 --> Dec 2014 N=20 --> 4 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2015 --> Jun 2014
- atorvastatin / Generic mfg.
Enrollment open: Atorvastatin in Active Vitiligo (clinicaltrials.gov) - Oct 27, 2015
P2, N=28, Recruiting, Sponsor: Centre Hospitalier Universitaire de Nice
N=20 --> 4 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2015 --> Jun 2014 Not yet recruiting --> Recruiting
- Orfadin (nitisinone) / Astellas, SOBI
Trial primary completion date: Nitisinone for Type 1B Oculocutaneous Albinism (clinicaltrials.gov) - Oct 7, 2015
P1/2, N=50, Recruiting, Sponsor: National Eye Institute (NEI)
Not yet recruiting --> Recruiting Trial primary completion date: Dec 2015 --> Dec 2016
- New P1 trial: Effect of Procedural Variables on Outcome of Surgical Treatment of Vitiligo (clinicaltrials.gov) - Jul 29, 2015
P1, N=40, Completed, Sponsor: Cairo University
- | New P4 trial: Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo (clinicaltrials.gov) - Jul 22, 2015
P4, N=30, Recruiting, Sponsor: Johns Hopkins University
- Enrollment closed, Trial primary completion date: Excimer Light Treatment for Idiopathic Guttate Hypomelanosis: A Pilot Study (clinicaltrials.gov) - Jun 6, 2015
P=N/A, N=20, Active, not recruiting, Sponsor: Seton Family of Hospitals
Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Jun 2015
- | Enrollment open: Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo (clinicaltrials.gov) - Jun 4, 2015
P2/3, N=60, Recruiting, Sponsor: Rutgers, The State University of New Jersey
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Jun 2015 Not yet recruiting --> Recruiting
- New P4 trial: Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients (clinicaltrials.gov) - Jun 1, 2015
P4, N=10, Enrolling by invitation, Sponsor: Netherlands Institute for Pigment Disorders
- fluticasone propionate / Generic mfg.
Enrollment open, Trial initiation date, Combination therapy: Fractional Laser in Combination With UVB Therapy in Vitiligo Patients (clinicaltrials.gov) - May 29, 2015
P=N/A, N=20, Recruiting, Sponsor: Netherlands Institute for Pigment Disorders
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> May 2015
- Trial completion, Enrollment change, Trial primary completion date: Questionnaire and Laboratory Data on Vitiligo Vulgaris (clinicaltrials.gov) - May 26, 2015
P=N/A, N=57, Completed, Sponsor: St. Luke's-Roosevelt Hospital Center
Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> May 2015 Active, not recruiting --> Completed | N=300 --> 57 | Trial primary completion date: Sep 2014 --> Oct 2010
- Enrollment open, Trial primary completion date: Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo (clinicaltrials.gov) - May 13, 2015
P=N/A, N=1500, Recruiting, Sponsor: St. Luke's-Roosevelt Hospital Center
Active, not recruiting --> Completed | N=300 --> 57 | Trial primary completion date: Sep 2014 --> Oct 2010 Active, not recruiting --> Recruiting | Trial primary completion date: Mar 2015 --> Mar 2016
- atorvastatin / Generic mfg.
New P2 trial: Atorvastatin in Active Vitiligo (clinicaltrials.gov) - May 4, 2015
P2, N=28, Not yet recruiting, Sponsor: Centre Hospitalier Universitaire de Nice
- simvastatin / Generic mfg.
Trial completion, Enrollment change: Clinical Trial of Simvastatin to Treat Generalized Vitiligo (clinicaltrials.gov) - Mar 12, 2015
P2, N=15, Completed, Sponsor: University of Massachusetts, Worcester
Active, not recruiting --> Recruiting | Trial primary completion date: Mar 2015 --> Mar 2016 Active, not recruiting --> Completed | N=50 --> 15
- Enrollment closed, Trial primary completion date: Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo (clinicaltrials.gov) - Feb 3, 2015
P2, N=20, Active, not recruiting, Sponsor: Centro Studi Gised
Active, not recruiting --> Completed | N=50 --> 15 Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2015 --> Dec 2015
- Enrollment open: LUVIA: The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism (clinicaltrials.gov) - Jan 26, 2015
P=N/A, N=28, Recruiting, Sponsor: Johns Hopkins University
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2015 --> Dec 2015 Not yet recruiting --> Recruiting
- Trial completion, Trial primary completion date: Trial of L-DOPA as a Treatment to Improve Vision in Albinism (clinicaltrials.gov) - Dec 12, 2014
P2, N=47, Completed, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Dec 2014
- fluticasone propionate / Generic mfg.
Combination therapy: Fractional Laser in Combination With UVB Therapy in Vitiligo Patients (clinicaltrials.gov) - Nov 14, 2014
P=N/A, N=20, Not yet recruiting, Sponsor: Netherlands Institute for Pigment Disorders
- Enrollment open: Excimer Light Treatment for Idiopathic Guttate Hypomelanosis: A Pilot Study (clinicaltrials.gov) - Sep 30, 2014
P=N/A, N=20, Recruiting, Sponsor: Seton Family of Hospitals
Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Dec 2014 Not yet recruiting --> Recruiting
- tacrolimus topical / Generic mfg.
Enrollment change, Trial termination: Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control (clinicaltrials.gov) - Sep 5, 2014
P2/3, N=35, Terminated, Sponsor: Centre Hospitalier Universitaire de Nice
Not yet recruiting --> Recruiting N=50 --> 35 | Recruiting --> Terminated
- Trial primary completion date: Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo (clinicaltrials.gov) - Jul 30, 2014
P2, N=20, Recruiting, Sponsor: Centro Studi Gised
N=50 --> 35 | Recruiting --> Terminated Trial primary completion date: Sep 2014 --> Feb 2015
- Clinical: LUVIA: The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism (clinicaltrials.gov) - Jul 25, 2014
P=N/A, N=28, Not yet recruiting, Sponsor: Johns Hopkins University
- || New P2/3 trial: Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo (clinicaltrials.gov) - Jul 16, 2014
P2/3, N=60, Not yet recruiting, Sponsor: Rutgers, The State University of New Jersey
- New P1 trial: Gingival Depigmentation by Diode Laser (clinicaltrials.gov) - May 19, 2014
P1, N=19, Completed, Sponsor: Shahid Beheshti Medical University
- Trial primary completion date: Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo (clinicaltrials.gov) - May 12, 2014
P=N/A, N=1500, Active, not recruiting, Sponsor: St. Luke's-Roosevelt Hospital Center
Trial primary completion date: Sep 2014 --> Feb 2015 Trial primary completion date: Mar 2012 --> Mar 2015
- Trial primary completion date: Questionnaire and Laboratory Data on Vitiligo Vulgaris (clinicaltrials.gov) - May 12, 2014
P=N/A, N=300, Active, not recruiting, Sponsor: St. Luke's-Roosevelt Hospital Center
Trial primary completion date: Mar 2012 --> Mar 2015 Trial primary completion date: Aug 2013 --> Sep 2014
- Trial completion date: Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo (clinicaltrials.gov) - May 12, 2014
P=N/A, N=1500, Active, not recruiting, Sponsor: St. Luke's-Roosevelt Hospital Center
Trial primary completion date: Aug 2013 --> Sep 2014 Trial completion date: Mar 2012 --> Mar 2015
- Trial completion date: Questionnaire and Laboratory Data on Vitiligo Vulgaris (clinicaltrials.gov) - May 12, 2014
P=N/A, N=300, Active, not recruiting, Sponsor: St. Luke's-Roosevelt Hospital Center
Trial completion date: Mar 2012 --> Mar 2015 Trial completion date: Aug 2013 --> Sep 2014
- Enrollment closed: Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo (clinicaltrials.gov) - May 12, 2014
P=N/A, N=1500, Active, not recruiting, Sponsor: St. Luke's-Roosevelt Hospital Center
Trial completion date: Aug 2013 --> Sep 2014 Recruiting --> Active, not recruiting
- Enrollment closed: Questionnaire and Laboratory Data on Vitiligo Vulgaris (clinicaltrials.gov) - May 12, 2014
P=N/A, N=300, Active, not recruiting, Sponsor: St. Luke's-Roosevelt Hospital Center
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Orfadin (nitisinone) / Astellas, SOBI
Enrollment open: Nitisinone for Type 1B Oculocutaneous Albinism (clinicaltrials.gov) - Feb 18, 2014
P1/2, N=8, Recruiting, Sponsor: National Eye Institute (NEI)
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting